JUST IN: FDA Authorizes Merck Pill as Second COVID-19 Home Treatment Pill …Sort of Like Ivermectin
One day after the authorization of the Pfizer pill, the U.S. Food and Drug Administration issued an emergency use authorization for Merck’s molnupiravir antiviral pill for the treatment of COVID-19 infection on Thursday.
“Today’s authorization provides an additional treatment option against the COVID-19 virus in the form of a pill that can be taken orally. Molnupiravir is limited to situations where other FDA-authorized treatments for COVID-19 are inaccessible or are not clinically appropriate and will be a useful treatment option for some patients with COVID-19 at high risk of hospitalization or death. As new variants of the virus continue to emerge, it is crucial to expand the country’s arsenal of COVID-19 therapies using emergency use authorization, while continuing to generate additional data on their safety and effectiveness,” said Patrizia Cavazzoni,
